Literature DB >> 12854102

Randomized clinical trial and economic analysis of four-layer compression bandaging for venous ulcers.

J F O'Brien1, P A Grace, I J Perry, A Hannigan, M Clarke Moloney, P E Burke.   

Abstract

BACKGROUND: The aim of this study was to compare the cost-effectiveness of four-layer compression bandaging for venous leg ulcers with that of other available treatments.
METHODS: In this pragmatic trial, 200 patients with a venous leg ulcer were randomized either to four-layer bandaging (intervention group; n = 100) or to continue their usual system of care (control group; n = 100). The follow-up for each patient was 12 weeks. Analysis was by intention to treat; the main outcome measures were time to healing and cost to the health board per leg healed.
RESULTS: Baseline characteristics were well matched in the two groups. The Kaplan-Meier estimate of the healing rate at 3 months was 54 per cent with four-layer bandaging and 34 per cent in the control group. Throughout the 3 months, four-layer bandaging healed leg ulcers significantly earlier (P = 0.006). There was a significant reduction in the median cost per leg healed with four-layer bandaging (euro 210 versus euro 234; P = 0.040).
CONCLUSION: Four-layer bandaging is currently the most effective method of treating venous leg ulcers in a community setting. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12854102     DOI: 10.1002/bjs.4167

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Cost-effective faster wound healing with a sustained silver-releasing foam dressing in delayed healing leg ulcers--a health-economic analysis.

Authors:  Elizabeth Scanlon; Tonny Karlsmark; David J Leaper; Kate Carter; Peter B Poulsen; Kristian Hart-Hansen; Tina W Hahn
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

2.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

3.  Health-related quality of life during four-layer compression bandaging for venous ulcer disease: a randomised controlled trial.

Authors:  M Clarke-Moloney; J F O'Brien; P A Grace; P E Burke
Journal:  Ir J Med Sci       Date:  2005 Apr-Jun       Impact factor: 1.568

4.  Experience with vacuum-assisted closure device in the management of benign chronic leg ulcers.

Authors:  Bc Jiburum; Ko Opara; Ic Nwagbara
Journal:  J West Afr Coll Surg       Date:  2011-01

Review 5.  Preventing venous ulcer recurrence: a review.

Authors:  Kathryn R Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

Review 6.  Venous leg ulcers.

Authors:  E Andrea Nelson; June Jones
Journal:  BMJ Clin Evid       Date:  2008-09-15

7.  A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers.

Authors:  Christine J Moffatt; Lynfa Edwards; Mark Collier; Terry Treadwell; Michael Miller; Laura Shafer; Gary Sibbald; Alain Brassard; Andrea McIntosh; Alex Reyzelman; Patricia Price; Stacia Merkel Kraus; Shelley-Ann Walters; Keith Harding
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

8.  Compression therapy for ulcers: The science and the art.

Authors:  Shashi B Gogia; Arun R Gogia
Journal:  Indian J Plast Surg       Date:  2012-05

Review 9.  Compression for venous leg ulcers.

Authors:  Susan O'Meara; Nicky Cullum; E Andrea Nelson; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

10.  Cost-effectiveness of compression technologies for evidence-informed leg ulcer care: results from the Canadian Bandaging Trial.

Authors:  Ba' Pham; Margaret B Harrison; Maggie H Chen; Meg E Carley
Journal:  BMC Health Serv Res       Date:  2012-10-02       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.